CClinicalTrials.gg
Status unknownNCT05330728Updated Apr 15, 2022

Comparison of the Effects of Abdominal Massage and Kinesio Taping in Women With Chronic Constipation

An interventional study of Suggestions for lifestyle changes+ Abdominal massage and Suggestions for lifestyle changes+ Kinesio taping in Constipation, sponsored by Ankara Yildirim Beyazıt University. Status unknown. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-04-15.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The aim of this study is to compare the effects of abdominal massage and kinesio taping on constipation severity, quality of life, bowel habits and perception of recovery in women with chronic constipation.

Read the detailed description

Constipation is not a disease but a subjective symptom characterized by inadequate defecation, the definition of which varies from person to person. It is known that abdominal massage, which is one of the physiotherapy approaches, reduces the severity of gastrointestinal symptoms and increases bowel movements. Kinesio taping applied for constipation can also increase bowel movement, increase the frequency of defecation and decrease the duration of defecation. However, there is a need for studies comparing the effects of these two different applications.

02

Conditions studied

  • Constipation

Browse trials for

03

In context

Constipation

1,018 studies on the registry are indexed under Constipation; 139 are open to participants now.

This study's planned enrollment of 60 is below the median of 80 across 850 interventional studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 228 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • 18 to 65 years of age
  • Having been diagnosed with chronic constipation according to the Rome 4 diagnostic criteria by a gastroenterologist
  • Being volunteer

Exclusion criteria

Exclusion Criteria:

  • Concomitant colon or gastrointestinal problems
  • Body mass index >35 kg/m2
  • Those who have difficulty defecating, those with anorectal dyssynergia
  • Being pregnant
  • Having neurological, metabolic and/or malignant disease
  • Having an open wound, mass, infection and/or hernia in the area to be massaged
  • Having abdominal surgery or abdominal radiotherapy in the last 1 year
  • Having a mental problem that prevents cooperation
  • Taking laxative therapy at least 4 weeks before participating in the study
  • To have received physiotherapy and rehabilitation applications related to constipation in the last 1 year
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Massage group

    Suggestions for lifestyle changes + abdominal massage will be performed.

    Other: Suggestions for lifestyle changes+ Abdominal massage

  • Active comparator
    Taping group

    Suggestions for Lifestyle Changes + Kinesio taping will be performed.

    Other: Suggestions for lifestyle changes+ Kinesio taping

  • Other
    Control group

    Suggestions for lifestyle changes will be performed.

    Other: Suggestions for lifestyle changes

Interventions

  • OtherSuggestions for lifestyle changes+ Abdominal massage

    Suggestions for lifestyle changes+ abdominal massage will be applied. Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Abdominal massage will be applied 3 times a week for 4 weeks.

  • OtherSuggestions for lifestyle changes+ Kinesio taping

    Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once. Kinesio taping will be applied 3 times a week for 4 weeks.

  • OtherSuggestions for lifestyle changes

    Suggestions including regular and balanced diet, fluid consumption, regular walking and abdominal exercises and correct toilet habits will be given once.

06

What researchers measure

Primary outcomes

  1. Constipation severity

    Constipation severity will be evaluated with Constipation Severity Scale. According to constipation severity scale, women's defecation frequency, intensity and difficulty/difficulty during defecation will be determined. The scale, which includes sixteen questions, consists of 3 sub-groups: obstructive defecation, colonic inertia and pain. The score that can be obtained from the obstructive defecation subgroup is 0-28, the score that can be obtained from the colonic inertia subgroup is 0-29, and the score that can be obtained from the pain subgroup is between 0-16. The lowest total score that can be obtained from the constipation severity scale is 0, and the highest is 73. As the score obtained from the scale increases, the severity of the symptoms increases.

    Time frame: change from baseline at 4 weeks

Secondary outcomes

  1. Life quality

    Life quality will be evaluated with Constipation Quality of Life Scale. It includes a total of 28 items in 4 subscales: worries and concerns (11 items), physical discomfort (4 items), psychosocial discomfort (8 items), and satisfaction (5 items). Item scores of the five-point Likert-type scale range from 1 to 5. The highest score that can be obtained from the scale is 140, and the lowest score is 28. It is stated that as the scores obtained from the scale increase, the quality of life may also be negatively affected.

    Time frame: change from baseline at 4 weeks

  2. Bowel habits

    Bowel habits will be evaluated with 7-day bowel diary. This diary included items related to frequency of bowel movement, defecation time, feeling of incomplete evacuation, medication use, and changes in food and liquid consumption.

    Time frame: change from baseline at 4 weeks

  3. Stool consistency

    Stool consistency will be assessed using Bristol Stool Scale on a 7-point scale (from 1 to 7) which is a quick and useful indicator of colonic transit time: type 1 = separate hard lumps, like nuts; 2 = sausage shaped but lumpy; 3 = like a sausage or snake, but with cracks on its surface; 4 = like a sausage or snake, smooth and soft; 5 = soft blobs with clear-cut edges; 6 = fluffy pieces with ragged edges, a mushy stool; and 7 = water, no solid pieces.

    Time frame: change from baseline at 4 weeks

  4. Perception of recovery

    Perception of recovery will be evaluated using a 4-point Likert-type scale. Accordingly, women will be asked to choose one of the statements as "worse, same, better or better" regarding the decrease in the severity of constipation when compared before and after treatment

    Time frame: change from baseline at 4 weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05330728
Lead sponsor
Ankara Yildirim Beyazıt University
Responsible party
seyda toprak celenay (associate professor, Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Apr 15, 2022
Start date
Jun 15, 2022 (estimated)
Primary completion
Aug 15, 2022 (estimated)
Completion
Jun 15, 2023 (estimated)
Last update
Apr 15, 2022

Study contacts

Seyda Toprak Celenay
Contact
sydtoprak@hotmail.com
+90312 906 1000
Seyda Toprak Celenay
principal investigator · Ankara Yildirim Beyazıt University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion